z-logo
open-access-imgOpen Access
OR11-4 Teprotumumab Markedly Improves Disease-related Quality of Life: Lessons From Two Randomized, Placebo-controlled Trials
Author(s) -
Raymond S. Douglas,
Richard I. G. Holt,
Anahita Qashqai,
Saba Sile,
Terry J. Smith,
Claudia Vesel,
George J. Kahaly
Publication year - 2022
Publication title -
journal of the endocrine society
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.046
H-Index - 20
ISSN - 2472-1972
DOI - 10.1210/jendso/bvac150.1654
Subject(s) - diplopia , medicine , placebo , quality of life (healthcare) , randomized controlled trial , physical therapy , ophthalmology , pathology , nursing , alternative medicine

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom